Brokerages Set Tvardi Therapeutics, Inc. (NASDAQ:TVRD) PT at $55.50

Tvardi Therapeutics, Inc. (NASDAQ: TVRD - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, three have given a buy rating and one has given